Search Results - "Parker, C. E"

Current trends in quantitative proteomics – an update by Li, H., Han, J., Pan, J., Liu, T., Parker, C. E., Borchers, C. H.

“…Proteins can provide insights into biological processes at the functional level, so they are very promising biomarker candidates. The quantification of…”
Get full text

Observations of Multiple Nuclear Reaction Histories and Fuel-Ion Species Dynamics in Shock-Driven Inertial Confinement Fusion Implosions by Sio, H, Frenje, J A, Le, A, Atzeni, S, Kwan, T J T, Gatu Johnson, M, Kagan, G, Stoeckl, C, Li, C K, Parker, C E, Forrest, C J, Glebov, V, Kabadi, N V, Bose, A, Rinderknecht, H G, Amendt, P, Casey, D T, Mancini, R, Taitano, W T, Keenan, B, Simakov, A N, Chacón, L, Regan, S P, Sangster, T C, Campbell, E M, Seguin, F H, Petrasso, R D

“…Fuel-ion species dynamics in hydrodynamiclike shock-driven DT^{3}He-filled inertial confinement fusion implosion is quantitatively assessed for the first time…”
Get full text

Neutron-upscattering enhancement of the triple-alpha process by Bishop, J., Parker, C. E., Rogachev, G. V., Ahn, S., Koshchiy, E., Brandenburg, K., Brune, C. R., Charity, R. J., Derkin, J., Dronchi, N., Hamad, G., Jones-Alberty, Y., Kokalova, Tz, Massey, T. N., Meisel, Z., Ohstrom, E. V., Paneru, S. N., Pollacco, E. C., Saxena, M., Singh, N., Smith, R., Sobotka, L. G., Soltesz, D., Subedi, S. K., Voinov, A. V., Warren, J., Wheldon, C.

“…The neutron inelastic scattering of carbon-12, populating the Hoyle state, is a reaction of interest for the triple-alpha process. The inverse process (neutron…”
Get full text

Scandium in the open ocean: A comparison with other group 3 trivalent metals by Parker, C. E., Brown, M. T., Bruland, K. W.

“…Little is known about the distribution of scandium (Sc) in the open ocean. Since the 1970s there has been only one published depth profile of dissolved Sc. The…”
Get full text

GPR133 (ADGRD1), an adhesion G-protein-coupled receptor, is necessary for glioblastoma growth by Bayin, N S, Frenster, J D, Kane, J R, Rubenstein, J, Modrek, A S, Baitalmal, R, Dolgalev, I, Rudzenski, K, Scarabottolo, L, Crespi, D, Redaelli, L, Snuderl, M, Golfinos, J G, Doyle, W, Pacione, D, Parker, E C, Chi, A S, Heguy, A, MacNeil, D J, Shohdy, N, Zagzag, D, Placantonakis, D G

“…Glioblastoma (GBM) is a deadly primary brain malignancy with extensive intratumoral hypoxia. Hypoxic regions of GBM contain stem-like cells and are associated…”
Get full text

Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning by Kadiiska, M B, Gladen, B C, Baird, D D, Graham, L B, Parker, C E, Ames, B N, Basu, S, Fitzgerald, G A, Lawson, J A, Marnett, L J, Morrow, J D, Murray, D M, Plastaras, J, Roberts, 2nd, L J, Rokach, J, Shigenaga, M K, Sun, J, Walter, P B, Tomer, K B, Barrett, J C, Mason, R P

“…Plasma and urinary levels of malondialdehyde-like products (MDA) and isoprostanes were identified as markers of in vivo lipid peroxidation in an animal model…”
Get full text

An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease by Rieder, F., Bettenworth, D., Ma, C., Parker, C. E., Williamson, L. A., Nelson, S. A., van Assche, G., Di Sabatino, A., Bouhnik, Y., Stidham, R. W., Dignass, A., Rogler, G., Taylor, S. A., Stoker, J., Rimola, J., Baker, M. E., Fletcher, J. G., Panes, J., Sandborn, W. J., Feagan, B. G., Jairath, V.

“…Summary Background Fibrotic stricture is a common complication of Crohn's disease (CD) affecting approximately half of all patients. No specific anti‐fibrotic…”
Get full text

Fine Definition of the Epitope on the gp41 Glycoprotein of Human Immunodeficiency Virus Type 1 for the Neutralizing Monoclonal Antibody 2F5 by Parker, C E, Deterding, L J, Hager-Braun, C, Binley, J M, Schülke, N, Katinger, H, Moore, J P, Tomer, K B

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Mixed-gas model for predicting decompression sickness in rats by Lillo, R. S, Parker, E. C

“…1  Biomedical Research Department, Navy Experimental Diving Unit, Panama City, Florida 32407-7015; and 2  Diving and Environmental Physiology Department, Naval…”
Get full text

First Observation of the β 3 α p Decay of O 13 via β -Delayed Charged-Particle Spectroscopy by Bishop, J., Rogachev, G. V., Ahn, S., Barbui, M., Cha, S. M., Harris, E., Hunt, C., Kim, C. H., Kim, D., Kim, S. H., Koshchiy, E., Luo, Z., Park, C., Parker, C. E., Pollacco, E. C., Roeder, B. T., Roosa, M., Saastamoinen, A., Scriven, D. P.

Get full text

Systematic review with meta‐analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis by Ma, C., Guizzetti, L., Panaccione, R., Fedorak, R. N., Pai, R. K., Parker, C. E., Nguyen, T. M., Khanna, R., Vande Casteele, N., D'Haens, G., Sandborn, W. J., Feagan, B. G., Jairath, V.

“…Summary Background Regulatory requirements for claims of mucosal healing in ulcerative colitis (UC) will require demonstration of both endoscopic and…”
Get full text

Reliability of histologic assessment in patients with eosinophilic oesophagitis by Warners, M. J., Ambarus, C. A., Bredenoord, A. J., Verheij, J., Lauwers, G. Y., Walsh, J. C., Katzka, D. A., Nelson, S., Viegen, T., Furuta, G. T., Gupta, S. K., Stitt, L., Zou, G., Parker, C. E., Shackelton, L. M., D`Haens, G. R., Sandborn, W. J., Dellon, E. S., Feagan, B. G., Collins, M. H., Jairath, V., Pai, R. K.

“…Summary Background The validity of the eosinophilic oesophagitis (EoE) histologic scoring system (EoEHSS) has been demonstrated, but only preliminary…”
Get full text

Randomised non‐inferiority trial: 1600 mg versus 400 mg tablets of mesalazine for the treatment of mild‐to‐moderate ulcerative colitis by D'Haens, G. R., Sandborn, W. J., Zou, G., Stitt, L. W., Rutgeerts, P. J., Gilgen, D., Jairath, V., Hindryckx, P., Shackelton, L. M., Vandervoort, M. K., Parker, C. E., Muller, C., Pai, R. K., Levchenko, O., Marakhouski, Y., Horynski, M., Mikhailova, E., Kharchenko, N., Pimanov, S., Feagan, B. G.

“…Summary Background High concentration mesalazine formulations are more convenient than conventional low concentration formulations for the treatment of…”
Get full text

Moderate alcohol consumption and levels of antioxidant vitamins and isoprostanes in postmenopausal women by Hartman, T.J, Baer, D.J, Graham, L.B, Stone, W.L, Gunter, E.W, Parker, C.E, Albert, P.S, Dorgan, J.F, Clevidence, B.A, Campbell, W.S

“…Background: Although alcohol intake has been positively associated with breast cancer risk in epidemiologic studies, the mechanisms mediating this association…”
Get full text

Systematic review with meta‐analysis: placebo rates in induction and maintenance trials of Crohn's disease by Jairath, V., Zou, G., Parker, C. E., MacDonald, J. K., Mosli, M. H., AlAmeel, T., Al Beshir, M., AlMadi, M., Al‐Taweel, T., Atkinson, N. S. S., Biswas, S., Chapman, T. P., Dulai, P. S., Glaire, M. A., Hoekman, D., Kherad, O., Koutsoumpas, A., Minas, E., Restellini, S., Samaan, M. A., Khanna, R., Levesque, B. G., D'Haens, G., Sandborn, W. J., Feagan, B. G.

“…Summary Background Minimising placebo response is essential for drug development. Aim To conduct a meta‐analysis to determine placebo response and remission…”
Get full text

Systematic review with meta‐analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's disease by Ma, C., Dutton, S. J., Cipriano, L. E., Singh, S., Parker, C. E., Nguyen, T. M., Guizzetti, L., Gregor, J. C., Chande, N., Hindryckx, P., Feagan, B. G., Jairath, V.

“…Summary Background Aminosalicylates are the most frequently prescribed drugs for patients with Crohn's disease (CD), yet evidence to support their efficacy as…”
Get full text

Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? by Kadiiska, M B, Gladen, B C, Baird, D D, Germolec, D, Graham, L B, Parker, C E, Nyska, A, Wachsman, J T, Ames, B N, Basu, S, Brot, N, Fitzgerald, G A, Floyd, R A, George, M, Heinecke, J W, Hatch, G E, Hensley, K, Lawson, J A, Marnett, L J, Morrow, J D, Murray, D M, Plastaras, J, Roberts, 2nd, L J, Rokach, J, Shigenaga, M K, Sohal, R S, Sun, J, Tice, R R, Van Thiel, D H, Wellner, D, Walter, P B, Tomer, K B, Mason, R P, Barrett, J C

“…Oxidation products of lipids, proteins, and DNA in the blood, plasma, and urine of rats were measured as part of a comprehensive, multilaboratory validation…”
Get full text

Evaluating Joint Morbidity after Chondral Harvest for Autologous Chondrocyte Implantation (ACI): A Study of ACI-Treated Ankles and Hips with a Knee Chondral Harvest by McCarthy, Helen S., Richardson, James B., Parker, Jane C. E., Roberts, Sally

“…Objective To establish if harvesting cartilage to source chondrocytes for autologous chondrocyte implantation (ACI) results in donor site morbidity. Design…”
Get full text

Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers by Gill, M D, Bramble, M G, Hull, M A, Mills, S J, Morris, E, Bradburn, D M, Bury, Y, Parker, C E, Lee, T J W, Rees, C J

“…Background: Colorectal cancers (CRCs) detected through the NHS Bowel Cancer Screening Programme (BCSP) have been shown to have a more favourable outcome…”
Get full text

Evaluation of a two-stage testing algorithm for the diagnosis of respiratory viral infections by Gardiner, B.J., Parker, C.E.V., Rabson, A.R., Snydman, D.R., Doron, S.

“…New on-demand multiplex molecular respiratory viral diagnostics offer superior performance although can be expensive and some platforms cannot process multiple…”
Get full text